Cargando…

Hair Growth Promotion by δ-Opioid Receptor Activation

Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Mei, Choi, Nahyun, Balboni, Gianfranco, Xia, Ying, Sung, Jong-Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551727/
https://www.ncbi.nlm.nih.gov/pubmed/34148869
http://dx.doi.org/10.4062/biomolther.2021.064
_version_ 1784591224104026112
author Zheng, Mei
Choi, Nahyun
Balboni, Gianfranco
Xia, Ying
Sung, Jong-Hyuk
author_facet Zheng, Mei
Choi, Nahyun
Balboni, Gianfranco
Xia, Ying
Sung, Jong-Hyuk
author_sort Zheng, Mei
collection PubMed
description Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epidermal component of hair follicle in human and rodents. The expression of DOR was high in the anagen phase, but it was low in the catagen and telogen phases during mouse hair cycle. Topical application of UFP-512, a specific DOR agonist, significantly accelerated the induction of the anagen in C(3)H mice. Topical application of UFP-512 also increased the hair length in hair organ cultures and promoted the proliferation and the migration of outer root sheath (ORS) cells. Similarly, pharmacological inhibition of DOR by naltrindole significantly inhibited the anagen transition process and decreased hair length in hair organ cultures. Thus, we further examined whether Wnt/β-catenin pathway was related to the effects of DOR on hair growth. We found that Wnt/β-catenin pathway was activated by UFP-512 and siRNA for β-catenin attenuated the UFP-512 induced proliferation and migration of ORS cells. Collectively, result established that DOR was involved in hair cycle regulation, and that DOR agonists such as UFP-512 should be developed for novel hair-loss treatment.
format Online
Article
Text
id pubmed-8551727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Applied Pharmacology
record_format MEDLINE/PubMed
spelling pubmed-85517272021-10-31 Hair Growth Promotion by δ-Opioid Receptor Activation Zheng, Mei Choi, Nahyun Balboni, Gianfranco Xia, Ying Sung, Jong-Hyuk Biomol Ther (Seoul) Original Article Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epidermal component of hair follicle in human and rodents. The expression of DOR was high in the anagen phase, but it was low in the catagen and telogen phases during mouse hair cycle. Topical application of UFP-512, a specific DOR agonist, significantly accelerated the induction of the anagen in C(3)H mice. Topical application of UFP-512 also increased the hair length in hair organ cultures and promoted the proliferation and the migration of outer root sheath (ORS) cells. Similarly, pharmacological inhibition of DOR by naltrindole significantly inhibited the anagen transition process and decreased hair length in hair organ cultures. Thus, we further examined whether Wnt/β-catenin pathway was related to the effects of DOR on hair growth. We found that Wnt/β-catenin pathway was activated by UFP-512 and siRNA for β-catenin attenuated the UFP-512 induced proliferation and migration of ORS cells. Collectively, result established that DOR was involved in hair cycle regulation, and that DOR agonists such as UFP-512 should be developed for novel hair-loss treatment. The Korean Society of Applied Pharmacology 2021-11-01 2021-06-21 /pmc/articles/PMC8551727/ /pubmed/34148869 http://dx.doi.org/10.4062/biomolther.2021.064 Text en Copyright © 2021, The Korean Society of Applied Pharmacology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Zheng, Mei
Choi, Nahyun
Balboni, Gianfranco
Xia, Ying
Sung, Jong-Hyuk
Hair Growth Promotion by δ-Opioid Receptor Activation
title Hair Growth Promotion by δ-Opioid Receptor Activation
title_full Hair Growth Promotion by δ-Opioid Receptor Activation
title_fullStr Hair Growth Promotion by δ-Opioid Receptor Activation
title_full_unstemmed Hair Growth Promotion by δ-Opioid Receptor Activation
title_short Hair Growth Promotion by δ-Opioid Receptor Activation
title_sort hair growth promotion by δ-opioid receptor activation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551727/
https://www.ncbi.nlm.nih.gov/pubmed/34148869
http://dx.doi.org/10.4062/biomolther.2021.064
work_keys_str_mv AT zhengmei hairgrowthpromotionbydopioidreceptoractivation
AT choinahyun hairgrowthpromotionbydopioidreceptoractivation
AT balbonigianfranco hairgrowthpromotionbydopioidreceptoractivation
AT xiaying hairgrowthpromotionbydopioidreceptoractivation
AT sungjonghyuk hairgrowthpromotionbydopioidreceptoractivation